News
Archive
Novadip secures €10.4 million financing to complete pivotal Phase 3 trial
Zeotap launches Open CDP: the first fully composable CDP that runs on open-source compute and the customer’s own lakehouse
PlanetiQ selected for NOAA’s Space-Based Environmental Monitoring IDIQ
OSCP qualifies as a supplier to Canada’s Defence Drone Initiative Marketplace in three streams
Achronix announces availability of high-performance JESD204C IP Core for Speedster7t FPGAs
Paragraf launches PMF2002 GFET Platform and Enterprise Reader, expanding sensing portfolio
Back To News
October 17, 2017
Biovex
Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.